Mr Holveck was most recently president of Johnson & Johnson Development Corporation and vice president, corporate development of Johnson & Johnson. He received a BS in education and science from West Chester University.
Roger Kimmel, chairman of the board of directors of Endo, said: “Dave Holveck is the ideal executive to lead Endo Pharmaceuticals as it pursues growth opportunities and enhanced shareholder value. He has a track record of strong performance, successfully managing product development, building great organizations and creating value.”